FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA

Clinical trials for FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA trials appear

Sign up with your email to follow new studies for FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Ultra-Fast CAR-T cells aim to beat back tough lymphomas

⭐️ CURE ⭐️ Not yet recruiting

This phase 2 trial tests whether a new CAR-T cell therapy called UF-KURE19 can effectively treat adults with relapsed or refractory B-cell non-Hodgkin lymphomas, including large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The therapy is made from a patient's…

Matched conditions: FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA

Phase: PHASE2 • Sponsor: Kure Cells, INC • Aim: ⭐️ CURE ⭐️

Last updated Jul 22, 2026 00:00 UTC

FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA

Get alerted when new FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA trials appear

Ultra-Fast CAR-T cells aim to beat back tough lymphomas